Literature DB >> 221093

MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.

A P Chahinian, E M Mandel, J F Holland, I S Jaffrey, A S Teirstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 221093     DOI： 10.1002/1097-0142(197905)43:5<1590::aid-cncr2820430504>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

Review 1.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 2.  Chemotherapy of advanced non-small cell lung cancer. A review.

Authors:  B J Takasugi; T P Miller
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

3.  Chemotherapy of non-small cell lung cancer: clinical trials at the Memorial Sloan-Kettering Cancer Center.

Authors:  R J Gralla; R E Wittes; E S Casper; D P Kelsen; E Cvitkovic; G B Magill; S E Krown; R B Golbey
Journal:  World J Surg       Date:  1981-09       Impact factor: 3.352

4.  Chemotherapy in non-small cell bronchial carcinoma.

Authors:  R Souhami
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

Review 5.  Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-10       Impact factor: 1.798

Review 6.  Current options in the treatment of non-small cell lung cancer.

Authors:  D Faulds
Journal:  Drugs       Date:  1992       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.